Psychiatry & Neurology, Neuromuscular Medicine · Phoenix, AZ
NPI
1417931767
Since 2005
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
240 W Thomas Rd, Suite 400
Phoenix, AZ, 85013
Phone (602) 406-6262
Groups this clinician bills Medicare through
Medicare paid, 2024
$726K
12,263 services
Medicare patients, 2024
296
Average age 71
Drug cost, 2024
$8.6M
986 prescriptions
Company payments, 2025
$38K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shafeeq S Ladha was code G0453 (continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)), 290 times for 17 patients. In total Shafeeq S Ladha billed 12,263 services in 45 codes, and Medicare paid $726K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 290 | 17 | $24.58 | $7,127 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 113 | 95 | $11.97 | $1,353 |
| 95938 Electrical Nerve Conductivity | Facility | 95 | 90 | $33.04 | $3,138 |
| 99215 Office E&M - Established | Office | 80 | 64 | $126.75 | $10K |
| 99214 Office E&M - Established | Office | 78 | 68 | $88.94 | $6,938 |
| 99232 Hospital E&M - Subsequent | Facility | 58 | 20 | $59.35 | $3,443 |
| 96365 Intravenous Infusion, Hydration | Office | 52 | 16 | $43.44 | $2,259 |
| 95886 Electrical Nerve Conductivity | Office | 36 | 33 | $74.17 | $2,670 |
| 95861 Electrical Nerve Conductivity | Facility | 29 | 28 | $56.46 | $1,637 |
| 99205 Office E&M - New | Office | 23 | 23 | $158.56 | $3,647 |
| 95939 Electrical Nerve Conductivity | Facility | 23 | 23 | $89.68 | $2,063 |
| 95885 Electrical Nerve Conductivity | Office | 18 | 18 | $47.56 | $856 |
| 99233 Hospital E&M - Subsequent | Facility | 15 | 12 | $91.15 | $1,367 |
| 95910 Electrical Nerve Conductivity | Office | 14 | 14 | $128.57 | $1,800 |
| 99238 Hospital Discharge Management | Facility | 11 | 11 | $62.00 | $682 |
By year: 2022 $509K for 7,403 services; 2023 $1.1M for 16,259 services; 2024 $726K for 12,263 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shafeeq S Ladha prescribed most often to Medicare patients was Radicava Ors (Edaravone), with 392 prescriptions and refills. In total Shafeeq S Ladha wrote 986 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Radicava Ors Edaravone | 392 | 392 | 59 | $5.6M |
| Riluzole Generic | 121 | 192 | 28 | $29K |
| Prednisone Generic | 83 | 131 | 15 | $556 |
| Evrysdi Risdiplam | 59 | 63 | Under 11 | $1.8M |
| Baclofen Generic | 46 | 72 | Under 11 | $793 |
| Clonazepam Generic | 41 | 42 | 11 | $156 |
| Relyvrio Sod Phenylbutyrat/Taurursodiol | 26 | 28 | 14 | $311K |
| Escitalopram Oxalate Generic | 22 | 30 | Under 11 | $116 |
| Glycopyrrolate Generic | 21 | 42 | Under 11 | $844 |
| Azathioprine Generic | 19 | 55 | Under 11 | $2,820 |
| Mycophenolate Mofetil Generic | 17 | 21 | Under 11 | $861 |
| Trazodone Hcl Generic | 16 | 16 | Under 11 | $32.18 |
| Firdapse Amifampridine Phosphate | 12 | 12 | Under 11 | $340K |
| Fluoxetine Hcl Generic | 11 | 11 | Under 11 | $69.69 |
Brand drugs: 509 claims; generic drugs: - claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shafeeq S Ladha $38K ($38K in general payments such as food, travel and fees) from 10 companies. The largest payer was Genentech USA, Inc. with $28K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.